Header Logo

Evaluation of salivary alpha-amylase as a potential biomarker of inhaled ?2-agonist response.

Evaluation of salivary alpha-amylase as a potential biomarker of inhaled ?2-agonist response. Ann Allergy Asthma Immunol. 2023 05; 130(5):664-665.

View in: PubMed